Literature DB >> 25654545

Pharmacologic agents targeting autophagy.

Helin Vakifahmetoglu-Norberg, Hong-guang Xia, Junying Yuan.   

Abstract

Autophagy is an important intracellular catabolic mechanism critically involved in regulating tissue homeostasis. The implication of autophagy in human diseases and the need to understand its regulatory mechanisms in mammalian cells have stimulated research efforts that led to the development of high-throughput screening protocols and small-molecule modulators that can activate or inhibit autophagy. Herein we review the current landscape in the development of screening technology as well as the molecules and pharmacologic agents targeting the regulatory mechanisms of autophagy. We also evaluate the potential therapeutic application of these compounds in different human pathologies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25654545      PMCID: PMC4382252          DOI: 10.1172/JCI73937

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  92 in total

1.  Autosis is a Na+,K+-ATPase-regulated form of cell death triggered by autophagy-inducing peptides, starvation, and hypoxia-ischemia.

Authors:  Yang Liu; Sanae Shoji-Kawata; Rhea M Sumpter; Yongjie Wei; Vanessa Ginet; Liying Zhang; Bruce Posner; Khoa A Tran; Douglas R Green; Ramnik J Xavier; Stanley Y Shaw; Peter G H Clarke; Julien Puyal; Beth Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

2.  Relieving autophagy and 4EBP1 from rapamycin resistance.

Authors:  Beat Nyfeler; Philip Bergman; Ellen Triantafellow; Christopher J Wilson; Yanyi Zhu; Branko Radetich; Peter M Finan; Daniel J Klionsky; Leon O Murphy
Journal:  Mol Cell Biol       Date:  2011-05-16       Impact factor: 4.272

3.  Role of autophagy in histone deacetylase inhibitor-induced apoptotic and nonapoptotic cell death.

Authors:  Noor Gammoh; Du Lam; Cindy Puente; Ian Ganley; Paul A Marks; Xuejun Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

4.  GDC-0980 is a novel class I PI3K/mTOR kinase inhibitor with robust activity in cancer models driven by the PI3K pathway.

Authors:  Jeffrey J Wallin; Kyle A Edgar; Jane Guan; Megan Berry; Wei Wei Prior; Leslie Lee; John D Lesnick; Cristina Lewis; Jim Nonomiya; Jodie Pang; Laurent Salphati; Alan G Olivero; Daniel P Sutherlin; Carol O'Brien; Jill M Spoerke; Sonal Patel; Letitia Lensun; Robert Kassees; Leanne Ross; Mark R Lackner; Deepak Sampath; Marcia Belvin; Lori S Friedman
Journal:  Mol Cancer Ther       Date:  2011-10-13       Impact factor: 6.261

Review 5.  Autophagy and aging.

Authors:  David C Rubinsztein; Guillermo Mariño; Guido Kroemer
Journal:  Cell       Date:  2011-09-02       Impact factor: 41.582

6.  Matrine, a novel autophagy inhibitor, blocks trafficking and the proteolytic activation of lysosomal proteases.

Authors:  Zhaohui Wang; Jun Zhang; Yuan Wang; Rui Xing; Chongqin Yi; Huishan Zhu; Xianwei Chen; Jiao Guo; Weixin Guo; Wenmei Li; Lin Wu; Youyong Lu; Siqi Liu
Journal:  Carcinogenesis       Date:  2012-09-22       Impact factor: 4.944

7.  Class I phosphatidylinositol 3-kinase inhibitor LY294002 activates autophagy and induces apoptosis through p53 pathway in gastric cancer cell line SGC7901.

Authors:  Chungen Xing; Baosong Zhu; Huihui Liu; Huihua Yao; Lifeng Zhang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2008-03       Impact factor: 3.848

8.  Identification of a candidate therapeutic autophagy-inducing peptide.

Authors:  Sanae Shoji-Kawata; Rhea Sumpter; Matthew Leveno; Grant R Campbell; Zhongju Zou; Lisa Kinch; Angela D Wilkins; Qihua Sun; Kathrin Pallauf; Donna MacDuff; Carlos Huerta; Herbert W Virgin; J Bernd Helms; Ruud Eerland; Sharon A Tooze; Ramnik Xavier; Deborah J Lenschow; Ai Yamamoto; David King; Olivier Lichtarge; Nick V Grishin; Stephen A Spector; Dora V Kaloyanova; Beth Levine
Journal:  Nature       Date:  2013-01-30       Impact factor: 49.962

9.  An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1.

Authors:  Carson C Thoreen; Seong A Kang; Jae Won Chang; Qingsong Liu; Jianming Zhang; Yi Gao; Laurie J Reichling; Taebo Sim; David M Sabatini; Nathanael S Gray
Journal:  J Biol Chem       Date:  2009-01-15       Impact factor: 5.157

10.  Lithium induces autophagy by inhibiting inositol monophosphatase.

Authors:  Sovan Sarkar; R Andres Floto; Zdenek Berger; Sara Imarisio; Axelle Cordenier; Matthieu Pasco; Lynnette J Cook; David C Rubinsztein
Journal:  J Cell Biol       Date:  2005-09-26       Impact factor: 10.539

View more
  96 in total

Review 1.  Stem cell guidance through the mechanistic target of rapamycin.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

2.  Non-canonical activation of NRF2: New insights and its relevance to disease.

Authors:  Matthew Dodson; Donna D Zhang
Journal:  Curr Pathobiol Rep       Date:  2017-04-19

Review 3.  Development of autophagy inducers in clinical medicine.

Authors:  Beth Levine; Milton Packer; Patrice Codogno
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

Review 4.  Autophagy: a druggable process that is deregulated in aging and human disease.

Authors:  Guido Kroemer
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

Review 5.  mTOR: a pharmacologic target for autophagy regulation.

Authors:  Young Chul Kim; Kun-Liang Guan
Journal:  J Clin Invest       Date:  2015-01-02       Impact factor: 14.808

Review 6.  Molecular definitions of autophagy and related processes.

Authors:  Lorenzo Galluzzi; Eric H Baehrecke; Andrea Ballabio; Patricia Boya; José Manuel Bravo-San Pedro; Francesco Cecconi; Augustine M Choi; Charleen T Chu; Patrice Codogno; Maria Isabel Colombo; Ana Maria Cuervo; Jayanta Debnath; Vojo Deretic; Ivan Dikic; Eeva-Liisa Eskelinen; Gian Maria Fimia; Simone Fulda; David A Gewirtz; Douglas R Green; Malene Hansen; J Wade Harper; Marja Jäättelä; Terje Johansen; Gabor Juhasz; Alec C Kimmelman; Claudine Kraft; Nicholas T Ktistakis; Sharad Kumar; Beth Levine; Carlos Lopez-Otin; Frank Madeo; Sascha Martens; Jennifer Martinez; Alicia Melendez; Noboru Mizushima; Christian Münz; Leon O Murphy; Josef M Penninger; Mauro Piacentini; Fulvio Reggiori; David C Rubinsztein; Kevin M Ryan; Laura Santambrogio; Luca Scorrano; Anna Katharina Simon; Hans-Uwe Simon; Anne Simonsen; Nektarios Tavernarakis; Sharon A Tooze; Tamotsu Yoshimori; Junying Yuan; Zhenyu Yue; Qing Zhong; Guido Kroemer
Journal:  EMBO J       Date:  2017-06-08       Impact factor: 11.598

7.  Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients.

Authors:  M A Frassanito; K De Veirman; V Desantis; L Di Marzo; D Vergara; S Ruggieri; T Annese; B Nico; E Menu; I Catacchio; R Ria; V Racanelli; M Maffia; E Angelucci; D Derudas; R Fumarulo; F Dammacco; D Ribatti; K Vanderkerken; A Vacca
Journal:  Leukemia       Date:  2015-10-21       Impact factor: 11.528

Review 8.  Autophagy in Pulmonary Diseases.

Authors:  Kiichi Nakahira; Maria Angelica Pabon Porras; Augustine M K Choi
Journal:  Am J Respir Crit Care Med       Date:  2016-11-15       Impact factor: 21.405

Review 9.  Autophagy in Cancer: Regulation by Small Molecules.

Authors:  Allison S Limpert; Lester J Lambert; Nicole A Bakas; Nicole Bata; Sonja N Brun; Reuben J Shaw; Nicholas D P Cosford
Journal:  Trends Pharmacol Sci       Date:  2018-12       Impact factor: 14.819

Review 10.  FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2015       Impact factor: 1.990

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.